CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 31 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,733,000 | -0.9% | 21,332,000 | +38.3% | 0.27% | -12.9% |
| Q1 2017 | $19,918,000 | -30.6% | 15,424,000 | -44.8% | 0.31% | -16.7% |
| Q4 2016 | $28,698,000 | +15164.9% | 27,924,000 | +14074.6% | 0.37% | +12266.7% |
| Q3 2016 | $188,000 | -98.1% | 197,000 | -98.6% | 0.00% | -98.9% |
| Q1 2016 | $9,730,000 | -55.9% | 14,300,000 | -44.2% | 0.28% | -41.7% |
| Q4 2015 | $22,040,000 | -38.6% | 25,630,000 | +19.0% | 0.48% | -44.0% |
| Q3 2015 | $35,921,000 | – | 21,545,000 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |